Stock Analysts’ price target changes for Tuesday, October 8th:
Abbott Laboratories (NYSE:ABT) had its target price raised by Royal Bank of Canada from $125.00 to $130.00. Royal Bank of Canada currently has an outperform rating on the stock.
Arista Networks (NYSE:ANET) had its target price raised by Citigroup Inc. from $385.00 to $460.00. The firm currently has a buy rating on the stock.
Broadcom (NASDAQ:AVGO) had its price target boosted by Cantor Fitzgerald from $200.00 to $225.00. They currently have an overweight rating on the stock.
Boston Scientific (NYSE:BSX) had its target price boosted by Royal Bank of Canada from $85.00 to $95.00. Royal Bank of Canada currently has an outperform rating on the stock.
Coeur Mining (NYSE:CDE) had its target price boosted by Canaccord Genuity Group Inc. from $7.00 to $7.75. Canaccord Genuity Group Inc. currently has a buy rating on the stock.
Corebridge Financial (NYSE:CRBG) had its price target boosted by Barclays PLC from $33.00 to $34.00. The firm currently has an equal weight rating on the stock.
DexCom (NASDAQ:DXCM) had its price target reduced by Royal Bank of Canada from $130.00 to $120.00. The firm currently has an outperform rating on the stock.
Brinker International (NYSE:EAT) had its target price increased by Citigroup Inc. from $69.00 to $83.00. They currently have a neutral rating on the stock.
Equitable (NYSE:EQH) had its target price raised by Barclays PLC from $59.00 to $60.00. The firm currently has an overweight rating on the stock.
Edwards Lifesciences (NYSE:EW) had its price target trimmed by Royal Bank of Canada from $85.00 to $75.00. They currently have an outperform rating on the stock.
Chesapeake Energy (NASDAQ:EXE) had its price target raised by Citigroup Inc. from $90.00 to $97.00. Citigroup Inc. currently has a buy rating on the stock.
Freeport-McMoRan (NYSE:FCX) had its target price raised by Scotiabank from $52.00 to $53.00. The firm currently has a sector perform rating on the stock.
F&G Annuities & Life (NYSE:FG) had its target price lowered by Barclays PLC from $45.00 to $44.00. Barclays PLC currently has an equal weight rating on the stock.
GlobalFoundries (NASDAQ:GFS) had its price target lowered by Cantor Fitzgerald from $55.00 to $40.00. The firm currently has a neutral rating on the stock.
Globus Medical (NYSE:GMED) had its target price raised by Royal Bank of Canada from $78.00 to $80.00. Royal Bank of Canada currently has an outperform rating on the stock.
Intuitive Surgical (NASDAQ:ISRG) had its target price boosted by Royal Bank of Canada from $515.00 to $525.00. The firm currently has an outperform rating on the stock.
Johnson & Johnson (NYSE:JNJ) had its price target increased by Royal Bank of Canada from $175.00 to $178.00. They currently have an outperform rating on the stock.
Jackson Financial (NYSE:JXN) had its price target raised by Barclays PLC from $109.00 to $111.00. Barclays PLC currently has an overweight rating on the stock.
Lincoln National (NYSE:LNC) had its price target increased by Barclays PLC from $35.00 to $36.00. Barclays PLC currently has an equal weight rating on the stock.
Medtronic (NYSE:MDT) had its target price increased by Royal Bank of Canada from $92.00 to $98.00. Royal Bank of Canada currently has a sector perform rating on the stock.
NRG Energy (NYSE:NRG) had its price target increased by Guggenheim from $77.00 to $118.00. They currently have a buy rating on the stock.
NXP Semiconductors (NASDAQ:NXPI) had its target price reduced by Cantor Fitzgerald from $350.00 to $270.00. They currently have an overweight rating on the stock.
Penumbra (NYSE:PEN) had its price target raised by Royal Bank of Canada from $205.00 to $222.00. The firm currently has an outperform rating on the stock.
Philip Morris International (NYSE:PM) had its target price raised by Citigroup Inc. from $118.50 to $132.00. They currently have a buy rating on the stock.
QUALCOMM (NASDAQ:QCOM) had its price target cut by Cantor Fitzgerald from $215.00 to $160.00. Cantor Fitzgerald currently has a neutral rating on the stock.
Reinsurance Group of America (NYSE:RGA) had its price target reduced by Barclays PLC from $255.00 to $250.00. Barclays PLC currently has an overweight rating on the stock.
Starbucks (NASDAQ:SBUX) had its price target raised by Citigroup Inc. from $98.00 to $99.00. Citigroup Inc. currently has a neutral rating on the stock.
Teck Resources (NYSE:TECK) (TSE:TECK) had its target price increased by Scotiabank from $78.00 to $79.00. They currently have a sector outperform rating on the stock.
Teleflex (NYSE:TFX) had its target price increased by Royal Bank of Canada from $260.00 to $275.00. Royal Bank of Canada currently has an outperform rating on the stock.
Texas Instruments (NASDAQ:TXN) had its target price lowered by Cantor Fitzgerald from $210.00 to $200.00. They currently have a neutral rating on the stock.
Unum Group (NYSE:UNM) had its target price lowered by Barclays PLC from $73.00 to $72.00. The firm currently has an overweight rating on the stock.
Voya Financial (NYSE:VOYA) had its target price increased by Barclays PLC from $84.00 to $85.00. Barclays PLC currently has an overweight rating on the stock.
Vistra (NYSE:VST) had its target price raised by Guggenheim from $133.00 to $177.00. The firm currently has a buy rating on the stock.
Wendy’s (NASDAQ:WEN) had its target price raised by Citigroup Inc. from $18.00 to $18.75. The firm currently has a neutral rating on the stock.
Zimmer Biomet (NYSE:ZBH) had its target price lowered by Royal Bank of Canada from $130.00 to $120.00. The firm currently has an outperform rating on the stock.
Zynex (NASDAQ:ZYXI) had its target price trimmed by Royal Bank of Canada from $12.00 to $11.00. Royal Bank of Canada currently has an outperform rating on the stock.
Receive News & Ratings for Abbott Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abbott Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.